查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1956270

日本运动医学市场规模、份额、趋势和预测：按产品、应用、最终用户和地区划分，2026-2034年

Japan Sports Medicine Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 5-7个工作天内

价格
简介目录

预计到 2025 年，日本运动医学市场规模将达到 4.2278 亿美元，到 2034 年将达到 6.63 亿美元，2026 年至 2034 年的复合年增长率为 5.13%。

由于人口老化但活跃度不断提高，以及休閒和竞技运动参与度的增加，日本的运动医学市场正经历强劲成长。先进的医疗基础设施、微创手术技术的进步以及再生医学疗法的日益普及，都提升了治疗效果。日本体育厅对体育锻炼的推广，以及为筹备重大国际体育赛事所做的准备，都促进了日本运动医学市场份额的扩大。

要点和见解：

  • 按产品划分：到 2025 年，身体重组领域将以 40.23% 的市场份额领先，这主要得益于对关节镜手术器械、骨折修復产品、骨生物製药和先进植入技术的需求不断增长，这些技术能够有效进行运动相关肌肉骨骼损伤的外科重组。
  • 按应用领域划分：到 2025 年，膝关节损伤将以 18.74% 的市场份额领先，这反映出运动员和活跃人群中需要专门的整形外科干预的疾病（如前交叉韧带断裂、半月软骨和退化性关节疾病）的患病率很高。
  • 按最终用户划分：到 2025 年，医院将占据最大的市场份额，达到 52.35%，这得益于领先的医疗机构提供的综合诊断能力、先进的外科手术设施、多学科运动医学团队和综合復健服务。
  • 按地区划分：到 2025 年，关东地区将占据最大的市场份额，达到 34%。这是因为东京都市圈集中了专业的运动医学设施、大学医院、职业运动队伍和先进的医疗基础设施。
  • 主要企业：日本运动医学市场的领先製造商正在拓展产品系列，推广再生医学技术，并加强与医疗机构的合作。对关节镜器械、生物导引植入和数位健康解决方案的投资正在加速创新，并有助于改善治疗效果。

随着医疗机构、体育组织和消费者积极采用创新疗法来治疗运动伤害和肌肉骨骼疾病，日本的运动医学市场蓬勃发展。完善的医疗基础设施和对技术创新的高度重视，推动了微创手术和再生医学的广泛应用。各年龄层健康意识的提升，促进了健身活动的参与，从而增加了对损伤预防和復健产品的需求。日本政府透过日本体育厅持续致力于推广体育运动，体现了其对全国运动员医疗保健和体能提升措施的持续投入。政府的支持，加上老龄化社会积极生活方式的趋势以及外科和復健设备的不断进步，预计将推动市场持续扩张。日本正积极筹备即将到来的国际体育赛事，并满足日益增长的各年龄层活跃人群不断变化的医疗需求。

日本运动医学市场的发展趋势：

再生医学的引入正在改变治疗通讯协定。

再生医学疗法的引入正在重塑日本的运动伤害治疗方法。富血小板血浆（PRP）注射、干细胞疗法和生物引导植入因其促进组织癒合和缩短恢復时间的有效性而已被广泛认可。医疗机构越来越认识到这些生物疗法在治疗运动相关肌肉骨骼损伤（从韧带断裂到软骨损伤）方面的潜力。这种向再生医学的转变反映了一种临床趋势，即註重恢復组织自然功能，而非仅仅依赖传统的手术干预，并正在推动日本运动医学市场的成长。

数位健康整合实现了远端患者监护

穿戴式科技和数位健康平台正在革新运动医学专业人士监测患者復健和运动表现的方式。先进的感测器能够持续追踪生理参数、运动模式和復健进展。这些技术在医疗和健身领域的日益普及，反映了日本消费者和医疗服务提供者对连线健诊解决方案日益增长的需求。这些创新有助于制定个人化治疗通讯协定、及早发现潜在损伤，并透过整合的远距远端医疗平台实现运动员与医疗服务提供者之间的无缝沟通。

透过微创手术技术改善患者预后

在日本，先进的关节镜和微创手术技术正逐渐成为运动医学机构的标准治疗方法。与传统开放性手术相比，这些技术能够减少组织损伤，缩短住院时间和復原期。先进的可视化系统、导航技术和专用器械使外科医生能够更精准地完成复杂的重组手术。对生物导引植入及类似技术的需求日益增长，显示人们越来越需要既能促进自然癒合过程又能最大限度地减少手术创伤的解决方案。

2026-2034年市场展望：

受人口结构变化、技术创新和医疗服务模式演变的推动，日本运动医学市场预计将在预测期内持续扩张。各年龄层运动参与率的提高，以及人们对运动伤害预防意识的增强，将持续推动对专业医疗产品和服务的需求。预计该市场2025年的营收将达到4.2278亿美元，到2034年将达到6.63亿美元，2026年至2034年的复合年增长率（CAGR）为5.13%。对先进外科技术、再生医学和数位健康整合的策略性投资将增强市场竞争力并改善病患治疗效果。

本报告解答的关键问题

1. 日本运动医学市场的规模有多大？

2. 日本运动医学市场的预期成长率是多少？

3. 在日本运动医学市场中，哪一种产品占最大的市占率？

4. 市场成长的主要驱动因素是什么？

5. 日本运动医学市场面临的主要挑战是什么？

目录

第一章：序言

第二章：调查范围与调查方法

  • 调查目标
  • 相关利益者
  • 数据来源
  • 市场估值
  • 调查方法

第三章执行摘要

第四章：日本运动医学市场：简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争资讯

第五章：日本运动医学市场：现状

  • 过去和当前的市场趋势（2020-2025）
  • 市场预测（2026-2034）

第六章：日本运动医学市场：依产品类别划分

  • 身体重组
  • 身体支持和恢復
  • 物理监测与评估
  • 压力衣
  • 配件

第七章：日本运动医学市场：依应用领域细分

  • 膝伤
  • 肩部受伤
  • 足部和踝部损伤
  • 髋部和鼠蹊部损伤
  • 肘部和腕部损伤
  • 背部和脊椎损伤
  • 其他的

第八章：日本运动医学市场－依最终用户细分

  • 医院
  • 整形外科诊所
  • 健身训练中心
  • 门诊手术中心（ASC）
  • 其他的

第九章：日本运动医学市场：依地区划分

  • 关东地区
  • 关西、近畿地区
  • 中部/中部地区
  • 九州和冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第十章：日本运动医学市场：竞争格局

  • 概述
  • 市场结构
  • 市场公司定位
  • 关键成功策略
  • 竞争对手仪錶板
  • 企业估值象限

第十一章：主要企业概况

第十二章：日本运动医学市场：产业分析

  • 驱动因素、限制因素和机会
  • 波特五力分析
  • 价值链分析

第十三章附录

简介目录
Product Code: SR112026A43897

The Japan sports medicine market size was valued at USD 422.78 Million in 2025 and is projected to reach USD 663.00 Million by 2034 , growing at a compound annual growth rate of 5.13% from 2026-2034 .

The Japan sports medicine market is experiencing robust expansion driven by the convergence of an aging yet increasingly active population and rising participation in recreational and competitive sports activities. Advanced healthcare infrastructure, technological innovations in minimally invasive surgical techniques, and growing adoption of regenerative medicine therapies are strengthening treatment outcomes. Government initiatives through the Japan Sports Agency promoting physical fitness, combined with preparations for major international sporting events, are enhancing the Japan sports medicine market share.

KEY TAKEAWAYS AND INSIGHTS:

  • By Product: Body reconstruction dominates the market with a share of 40.23% in 2025 , driven by rising demand for arthroscopic devices, fracture repair products, orthobiologics, and advanced implant technologies that enable effective surgical reconstruction of sports-related musculoskeletal injuries.
  • By Application: Knee injuries lead the market with a share of 18.74% in 2025 , reflecting the high prevalence of anterior cruciate ligament tears, meniscal damage, and degenerative joint conditions requiring specialized orthopedic interventions among athletes and active individuals.
  • By End User: Hospitals hold the largest share at 52.35% in 2025 , owing to comprehensive diagnostic capabilities, advanced surgical facilities, multidisciplinary sports medicine teams, and integrated rehabilitation services offered by major medical institutions.
  • By Region: Kanto Region represents the largest segment with 34% share in 2025 , supported by the concentration of specialized sports medicine facilities, university hospitals, professional sports teams, and advanced healthcare infrastructure in the Greater Tokyo metropolitan area.
  • Key Players: Leading manufacturers in the Japan sports medicine market are expanding product portfolios, advancing regenerative medicine technologies, and strengthening partnerships with healthcare institutions. Their investments in arthroscopic devices, bioinductive implants, and digital health solutions are accelerating innovation and improving treatment outcomes.

The Japan sports medicine market is advancing as healthcare providers, sports organizations, and consumers embrace innovative treatment solutions for athletic injuries and musculoskeletal conditions. The country's well-established healthcare infrastructure and emphasis on technological innovation are enabling widespread adoption of minimally invasive procedures and regenerative therapies. Growing health consciousness across generations is driving participation in fitness activities, subsequently increasing demand for injury prevention and rehabilitation products. Sustained governmental commitment to sports promotion through the Japan Sports Agency demonstrates continued investment in athlete healthcare and physical fitness initiatives nationwide. This governmental support, combined with demographic trends favoring active lifestyles among aging populations and continuous technological advancements in surgical devices and rehabilitation equipment, positions the market for continued expansion as the nation prepares for upcoming international sporting events and addresses the evolving healthcare needs of its increasingly active population across all age groups.

JAPAN SPORTS MEDICINE MARKET TRENDS:

Regenerative Medicine Adoption Transforming Treatment Protocols

The integration of regenerative medicine therapies is reshaping sports injury treatment approaches across Japan. Platelet-rich plasma injections, stem cell-based treatments, and bioinductive implants are gaining acceptance for their ability to accelerate tissue healing and reduce recovery times. Healthcare providers increasingly recognize the potential of these biological solutions for addressing sports-related musculoskeletal injuries, from ligament tears to cartilage damage. This shift toward regenerative approaches reflects broader clinical emphasis on restoring natural tissue function rather than relying solely on traditional surgical interventions, supporting the Japan sports medicine market growth.

Digital Health Integration Enabling Remote Patient Monitoring

Wearable technology and digital health platforms are revolutionizing how sports medicine professionals monitor patient recovery and athletic performance. Advanced sensors enable continuous tracking of physiological parameters, movement patterns, and rehabilitation progress. The growing adoption of these technologies across healthcare and fitness applications reflects increasing demand for connected health solutions among Japanese consumers and providers. These innovations facilitate personalized treatment protocols, early detection of potential injuries, and seamless communication between athletes and healthcare providers through integrated telehealth platforms.

Minimally Invasive Surgical Techniques Improving Patient Outcomes

Advanced arthroscopic procedures and minimally invasive surgical techniques are becoming standard practice in Japanese sports medicine facilities. These approaches offer reduced tissue trauma, shorter hospital stays, and accelerated rehabilitation timelines compared to traditional open surgeries. Sophisticated visualization systems, navigation technologies, and specialized instrumentation enable surgeons to perform complex reconstructive procedures with enhanced precision. The growing preference for bioinductive implants and similar technologies demonstrates the expanding demand for solutions that support natural healing processes while minimizing surgical invasiveness.

MARKET OUTLOOK 2026-2034:

The Japan sports medicine market is poised for sustained expansion throughout the forecast period, driven by demographic shifts, technological innovations, and evolving healthcare delivery models. Increasing sports participation rates across age groups, combined with growing awareness of injury prevention, will continue generating demand for specialized medical products and services. The market generated a revenue of USD 422.78 Million in 2025 and is projected to reach a revenue of USD 663.00 Million by 2034, growing at a compound annual growth rate of 5.13% from 2026-2034. Strategic investments in advanced surgical technologies, regenerative therapies, and digital health integration will strengthen market competitiveness and improve patient outcomes.

JAPAN SPORTS MEDICINE MARKET REPORT SEGMENTATION:

Product Insights:

  • Body Reconstruction
  • Fracture and Ligament Repair Products
  • Arthroscopy Devices
  • Implants
  • Orthobiologics
  • Prosthetics
  • Body Support and Recovery
  • Braces and Supports
  • Physiotherapy
  • Thermal Therapy
  • Ultrasound Therapy
  • Laser Therapy
  • Electrostimulation Therapy
  • Body Monitoring and Evaluation
  • Cardiac Monitoring
  • Respiratory Monitoring
  • Hemodynamic Monitoring
  • Musculoskeletal Monitoring
  • Compression Clothing
  • Accessories
  • Bandages
  • Disinfectants
  • Tapes
  • Others
  • Body reconstruction dominates with a market share of 40.23% of the total Japan sports medicine market in 2025 .
  • The body reconstruction segment encompasses arthroscopy devices, fracture and ligament repair products, orthobiologics, implants, and prosthetics essential for surgical treatment of sports injuries. Rising demand for advanced reconstructive solutions reflects the growing complexity of athletic injuries and patient expectations for complete functional restoration. In October 2023, Smith+Nephew launched its REGENETEN Bioinductive Implant in Japan at the 50th Annual Meeting of the Japan Shoulder Society, providing healing options for patients with rotator cuff tears ranging from partial thickness to massive full-thickness tears exceeding 5 centimeters.
  • Technological innovations in bioinductive materials, bioabsorbable implants, and minimally invasive surgical instrumentation are enhancing treatment outcomes and reducing recovery periods. Surgeons increasingly prefer arthroscopic approaches that minimize tissue trauma while enabling precise reconstruction of damaged ligaments, tendons, and cartilage. The segment benefits from ongoing research collaborations between medical device manufacturers and academic institutions developing next-generation orthopedic solutions tailored to the anatomical and physiological characteristics of Japanese patients, ensuring optimal surgical outcomes across diverse injury presentations.

Application Insights:

  • Knee Injuries
  • Shoulder Injuries
  • Foot and Ankle Injuries
  • Hip and Groin Injuries
  • Elbow and Wrist Injuries
  • Back and Spine Injuries
  • Knee injuries lead with a share of 18.74% of the total Japan sports medicine market in 2025 .
  • Knee injuries represent the most prevalent application category driven by high incidence of anterior cruciate ligament tears, meniscal damage, and patellofemoral disorders among athletes and active individuals. The anatomical complexity of the knee joint and biomechanical stresses during athletic activities necessitates specialized diagnostic and treatment approaches. Sports medicine professionals across Japan consistently observe knee-related conditions as among the most common presentations requiring intervention across all athletic populations.
  • Treatment modalities for knee injuries encompass arthroscopic reconstruction procedures, ligament repair techniques, cartilage restoration therapies, and comprehensive rehabilitation programs. The segment benefits from continuous advancements in surgical instrumentation, imaging technologies, and regenerative medicine applications that improve diagnostic accuracy and treatment efficacy. Growing participation in high-impact sports such as soccer, basketball, and skiing contributes to sustained demand for knee injury management solutions across professional, amateur, and recreational athletic populations throughout Japan.

End User Insights:

  • Hospitals
  • Orthopedic Specialty Clinics
  • Fitness and Training Centers
  • Ambulatory Surgical Centers (ASCs)
  • Hospitals exhibit a clear dominance with a 52.35% share of the total Japan sports medicine market in 2025 .
  • Hospitals serve as primary treatment centers for sports injuries requiring comprehensive diagnostic evaluation, surgical intervention, and post-operative rehabilitation. Major university hospitals and medical centers operate dedicated sports medicine departments staffed by orthopedic surgeons, sports medicine physicians, physical therapists, and athletic trainers. These institutions offer integrated services spanning injury assessment, advanced imaging, surgical treatment, and structured rehabilitation programs designed to restore athletes to competitive activity levels safely and efficiently.
  • The hospital segment benefits from substantial capital investments in advanced surgical technologies, including arthroscopic equipment, robotic-assisted surgery systems, and sophisticated imaging modalities. Leading institutions maintain partnerships with professional sports teams and national athletic organizations, providing specialized care for elite competitors while conducting clinical research advancing treatment protocols. Hospital-based sports medicine programs increasingly emphasize multidisciplinary approaches integrating orthopedic expertise with nutritional counseling, psychological support, and performance optimization services.

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • Kanto Region represents the leading segment with a 34% share of the total Japan sports medicine market in 2025 .
  • The Kanto Region dominates the Japan sports medicine market owing to the concentration of advanced healthcare infrastructure, specialized orthopedic facilities, and professional sports organizations in the Greater Tokyo metropolitan area. The region hosts numerous university hospitals, research institutions, and private specialty clinics offering comprehensive sports medicine services. In January 2025, Tokyo Sports and Orthopaedic Clinic established its Kitasando branch in Shibuya, featuring a five-story facility with MRI imaging, and 19 inpatient beds.
  • The region benefits from substantial population density, higher disposable incomes enabling access to premium healthcare services, and proximity to major sporting venues and athletic training facilities. Professional baseball, soccer, and Olympic sport organizations headquartered in the Kanto Region generate consistent demand for specialized injury treatment and prevention programs. The concentration of elite athletes and recreational sports enthusiasts creates a robust patient base seeking quality care. Additionally, the presence of leading medical device distributors and pharmaceutical companies facilitates rapid adoption of innovative sports medicine technologies throughout the regional healthcare network.

MARKET DYNAMICS:

Growth Drivers:

  • Why is the Japan Sports Medicine Market Growing?
  • Aging Yet Increasingly Active Population Driving Healthcare Demand
  • Japan's demographic profile significantly influences sports medicine demand as the nation maintains the world's highest proportion of elderly citizens while simultaneously experiencing rising fitness consciousness across age groups. In September 2024, people aged 65 and older comprised a record 29.3% of the country's population, while those 75 and above accounted for 16.8%. Despite advanced age, Japanese seniors demonstrate remarkable engagement in physical activities. A 2024 survey of 3,000 adults found that 54.8% played sports at least once a week, representing a substantial increase from 23.7% in 1992. This combination of longevity and active lifestyle generates sustained demand for sports medicine products addressing age-related musculoskeletal conditions alongside athletic injuries.
  • Government Investment Supporting Sports Infrastructure Development
  • Substantial governmental commitment to sports promotion and athlete healthcare strengthens the foundation for market expansion. The Ministry of Education, Culture, Sports, Science, and Technology and the Japan Sports Agency allocate significant budgetary resources toward national sports development initiatives, with dedicated funding streams designated for improving international competitiveness among Japanese athletes. National sports promotion plans outline comprehensive measures including healthcare provisions for athletes at all competitive levels. Ongoing preparations for major international sporting events hosted within Japan are driving infrastructure investments that benefit sports medicine service delivery nationwide. These governmental initiatives create favorable conditions for healthcare providers, equipment manufacturers, and rehabilitation specialists operating within the sports medicine sector.
  • Technological Advancements Enabling Superior Treatment Outcomes
  • Continuous innovations in medical devices, digital health platforms, and regenerative medicine therapies are transforming sports injury treatment capabilities. In April 2024, OMRON Healthcare acquired Luscii Healthtech, a digital health and remote consultation service platform provider, demonstrating the integration of advanced telehealth solutions into sports medicine practice. Wearable technology in Japan facilitates continuous patient monitoring and personalized rehabilitation protocols. Advances in arthroscopic instrumentation, bioinductive implants, and AI-powered diagnostic tools enable surgeons to achieve superior outcomes while minimizing recovery periods, driving adoption of premium sports medicine solutions across healthcare facilities.

Market Restraints:

  • What Challenges the Japan Sports Medicine Market is Facing?
  • High Treatment Costs Limiting Access
  • Premium pricing for advanced sports medicine technologies including imported orthopedic implants, robotic surgical systems, and regenerative therapies creates accessibility barriers for some patient populations. Insurance coverage limitations for innovative treatments such as stem cell therapies and platelet-rich plasma injections often require substantial out-of-pocket expenditures, potentially restricting market penetration.
  • Regulatory Complexity Affecting Product Introduction
  • Japan's stringent medical device regulatory framework, including requirements under the Act on Safety of Regenerative Medicine, necessitates comprehensive approval processes for innovative sports medicine products. Manufacturers must navigate extensive documentation, clinical validation, and certification requirements that extend timelines for introducing advanced treatment technologies to the market.
  • Geographic Disparities in Healthcare Access
  • Advanced sports medicine capabilities remain concentrated in major urban centers, creating access disparities for patients in rural and remote regions. Limited availability of specialized orthopedic facilities, certified sports medicine physicians, and comprehensive rehabilitation services outside metropolitan areas constrains market growth potential in underserved geographic segments.

COMPETITIVE LANDSCAPE:

  • The Japan sports medicine market exhibits a competitive landscape characterized by the presence of established multinational medical technology companies alongside domestic healthcare providers. Leading manufacturers focus on expanding product portfolios, advancing regenerative medicine technologies, and developing minimally invasive surgical solutions. Competition intensifies around arthroscopic devices, orthobiologic products, and digital health platforms. Strategic partnerships between medical device companies and academic institutions drive research innovation, while collaborations with professional sports organizations enhance market visibility and clinical validation of new technologies.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the Japan sports medicine market?

2. What is the projected growth rate of the Japan sports medicine market?

3. Which product held the largest Japan sports medicine market share?

4. What are the key factors driving market growth?

5. What are the major challenges facing the Japan sports medicine market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Sports Medicine Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Sports Medicine Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Sports Medicine Market - Breakup by Product

  • 6.1 Body Reconstruction
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Fracture and Ligament Repair Products
      • 6.1.3.2 Arthroscopy Devices
      • 6.1.3.3 Implants
      • 6.1.3.4 Orthobiologics
      • 6.1.3.5 Prosthetics
    • 6.1.4 Market Forecast (2026-2034)
  • 6.2 Body Support and Recovery
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Segmentation
      • 6.2.3.1 Braces and Supports
      • 6.2.3.2 Physiotherapy
        • 6.2.3.2.1 Thermal Therapy
        • 6.2.3.2.2 Ultrasound Therapy
        • 6.2.3.2.3 Laser Therapy
        • 6.2.3.2.4 Electrostimulation Therapy
    • 6.2.4 Market Forecast (2026-2034)
  • 6.3 Body Monitoring and Evaluation
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Segmentation
      • 6.3.3.1 Cardiac Monitoring
      • 6.3.3.2 Respiratory Monitoring
      • 6.3.3.3 Hemodynamic Monitoring
      • 6.3.3.4 Musculoskeletal Monitoring
    • 6.3.4 Market Forecast (2026-2034)
  • 6.4 Compression Clothing
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)
  • 6.5 Accessories
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2020-2025)
    • 6.5.3 Market Segmentation
      • 6.5.3.1 Bandages
      • 6.5.3.2 Disinfectants
      • 6.5.3.3 Tapes
      • 6.5.3.4 Others
    • 6.5.4 Market Forecast (2026-2034)

7 Japan Sports Medicine Market - Breakup by Application

  • 7.1 Knee Injuries
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Shoulder Injuries
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Foot and Ankle Injuries
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 Hip and Groin Injuries
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2020-2025)
    • 7.4.3 Market Forecast (2026-2034)
  • 7.5 Elbow and Wrist Injuries
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2020-2025)
    • 7.5.3 Market Forecast (2026-2034)
  • 7.6 Back and Spine Injuries
    • 7.6.1 Overview
    • 7.6.2 Historical and Current Market Trends (2020-2025)
    • 7.6.3 Market Forecast (2026-2034)
  • 7.7 Others
    • 7.7.1 Historical and Current Market Trends (2020-2025)
    • 7.7.2 Market Forecast (2026-2034)

8 Japan Sports Medicine Market - Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Orthopedic Specialty Clinics
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)
  • 8.3 Fitness and Training Centers
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Forecast (2026-2034)
  • 8.4 Ambulatory Surgical Centers (ASCs)
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2020-2025)
    • 8.4.3 Market Forecast (2026-2034)
  • 8.5 Others
    • 8.5.1 Historical and Current Market Trends (2020-2025)
    • 8.5.2 Market Forecast (2026-2034)

9 Japan Sports Medicine Market - Breakup by Region

  • 9.1 Kanto Region
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Breakup by Product
    • 9.1.4 Market Breakup by Application
    • 9.1.5 Market Breakup by End User
    • 9.1.6 Key Players
    • 9.1.7 Market Forecast (2026-2034)
  • 9.2 Kansai/Kinki Region
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Breakup by Product
    • 9.2.4 Market Breakup by Application
    • 9.2.5 Market Breakup by End User
    • 9.2.6 Key Players
    • 9.2.7 Market Forecast (2026-2034)
  • 9.3 Central/Chubu Region
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2020-2025)
    • 9.3.3 Market Breakup by Product
    • 9.3.4 Market Breakup by Application
    • 9.3.5 Market Breakup by End User
    • 9.3.6 Key Players
    • 9.3.7 Market Forecast (2026-2034)
  • 9.4 Kyushu-Okinawa Region
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2020-2025)
    • 9.4.3 Market Breakup by Product
    • 9.4.4 Market Breakup by Application
    • 9.4.5 Market Breakup by End User
    • 9.4.6 Key Players
    • 9.4.7 Market Forecast (2026-2034)
  • 9.5 Tohoku Region
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2020-2025)
    • 9.5.3 Market Breakup by Product
    • 9.5.4 Market Breakup by Application
    • 9.5.5 Market Breakup by End User
    • 9.5.6 Key Players
    • 9.5.7 Market Forecast (2026-2034)
  • 9.6 Chugoku Region
    • 9.6.1 Overview
    • 9.6.2 Historical and Current Market Trends (2020-2025)
    • 9.6.3 Market Breakup by Product
    • 9.6.4 Market Breakup by Application
    • 9.6.5 Market Breakup by End User
    • 9.6.6 Key Players
    • 9.6.7 Market Forecast (2026-2034)
  • 9.7 Hokkaido Region
    • 9.7.1 Overview
    • 9.7.2 Historical and Current Market Trends (2020-2025)
    • 9.7.3 Market Breakup by Product
    • 9.7.4 Market Breakup by Application
    • 9.7.5 Market Breakup by End User
    • 9.7.6 Key Players
    • 9.7.7 Market Forecast (2026-2034)
  • 9.8 Shikoku Region
    • 9.8.1 Overview
    • 9.8.2 Historical and Current Market Trends (2020-2025)
    • 9.8.3 Market Breakup by Product
    • 9.8.4 Market Breakup by Application
    • 9.8.5 Market Breakup by End User
    • 9.8.6 Key Players
    • 9.8.7 Market Forecast (2026-2034)

10 Japan Sports Medicine Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Products Offered
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Products Offered
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Products Offered
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Products Offered
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Products Offered
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Sports Medicine Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix